Design strategies for protein kinase inhibitors

Keykavous Parang, Gongqin Sun

Research output: Contribution to journalArticlepeer-review

38 Scopus citations


Deregulation of protein kinases due to mutation or overexpression is a hallmark of several diseases, for example, cancer, diabetes, inflammation and cardiovascular disorders. Consequently, there has been a growing interest in the discovery of protein kinase inhibitors as novel drugs. Here, we focus on key milestones and advances in protein kinase inhibitor drug discovery over the last year, with an emphasis on novel strategies such as targeting of single and multiple binding sites, inactive conformations of kinases, allosteric sites, regulatory domains and heat shock proteins. We will highlight recent developments for specific inhibitors in clinical studies for growth factor receptors, non-receptor tyrosine kinases and serine/threonine kinases.

Original languageEnglish (US)
Pages (from-to)617-629
Number of pages13
JournalCurrent Opinion in Drug Discovery and Development
Issue number5
StatePublished - Sep 2004
Externally publishedYes


  • Inhibitor design
  • Protein kinases
  • Selectivity
  • Serine/threonine kinases
  • Tyrosine kinases

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery


Dive into the research topics of 'Design strategies for protein kinase inhibitors'. Together they form a unique fingerprint.

Cite this